The Oncosearch | Oncotarget

Rituximab-induced HMGB1 release is associated with inhibition of STAT3 activity in human diffuse large B-cell lymphoma Research Paper

Tiansuo Zhao, He Ren, Xiuchao Wang, Pengfei Liu, Fan Yan, Wenna Jiang, Yang Li, Jing Li, John G Gribben, Li Jia, Jihui Hao

Published Jul 31, 2015 · Vol. 6, No. 29 · pp. 27816-27831

Targeting SOD1 induces synthetic lethal killing in BLM- and CHEK2-deficient colorectal cancer cells Research Paper

Babu V. Sajesh, Kirk J. McManus

Published Jul 31, 2015 · Vol. 6, No. 29 · pp. 27907-27922

Enhanced detection and comprehensive in situ phenotypic characterization of circulating and disseminated heteroploid epithelial and glioma tumor cells Research Paper

Feng Ge, Haishi Zhang, Daisy Dandan Wang, Linda Li, Peter Ping Lin

Published Jul 29, 2015 · Vol. 6, No. 29 · pp. 27049-27064

Analysis of SDHD promoter mutations in various types of melanoma Research Paper

Simone L. Scholz, Susanne Horn, Rajmohan Murali, Inga MÃ¶ller, Antje Sucker, Wiebke Sondermann, Mathias Stiller, Bastian Schilling, Elisabeth Livingstone, Lisa Zimmer, Henning Reis, Claudia H. Metz, Michael Zeschnigk, Annette Paschen, Klaus-Peter Steuhl, Dirk Schadendorf, Henrike Westekemper, Klaus G. Griewank

Published Jul 27, 2015 · Vol. 6, No. 28 · pp. 25868-25882

Hepatitis B virus-associated diffuse large B-cell lymphoma: unique clinical features, poor outcome, and hepatitis B surface antigen-driven origin Research Paper

Lijuan Deng, Yuqin Song, Ken H. Young, Shimin Hu, Ning Ding, Weiwei Song, Xianghong Li, Yunfei Shi, Huiying Huang, Weiping Liu, Wen Zheng, Xiaopei Wang, Yan Xie, Ningjing Lin, Meifeng Tu, Lingyan Ping, Zhitao Ying, Chen Zhang, Yingli Sun, Jun Zhu

Published Jul 22, 2015 · Vol. 6, No. 28 · pp. 25061-25073

The MYC/miR-17-92 axis in lymphoproliferative disorders: A common pathway with therapeutic potential Review

Michele Dal Bo, Riccardo Bomben, Luis HernÃ¡ndez, Valter Gattei

Published Jul 21, 2015 · Vol. 6, No. 23 · pp. 19381-19392

OSI-027 inhibits pancreatic ductal adenocarcinoma cell proliferation and enhances the therapeutic effect of gemcitabine both in vitro and in vivo Research Paper

Xiao Zhi, Wei Chen, Fei Xue, Chao Liang, Bryan Wei Chen, Yue Zhou, Liang Wen, Liqiang Hu, Jian Shen, Xueli Bai, Tingbo Liang

Published Jul 21, 2015 · Vol. 6, No. 28 · pp. 26230-26241

Genetic determinants of FOXM1 overexpression in epithelial ovarian cancer and functional contribution to cell cycle progression Research Paper

Carter J Barger, Wa Zhang, Joanna Hillman, Aimee B. Stablewski, Michael J. Higgins, Barbara C. Vanderhyden, Kunle Odunsi, Adam R. Karpf

Published Jul 16, 2015 · Vol. 6, No. 29 · pp. 27613-27627

Conditional survival estimate of acute-on-chronic hepatitis B liver failure: a dynamic prediction based on a multicenter cohort Research Paper

Ming- Hua Zheng, Sheng-Jie Wu, Ke-Qing Shi, Hua-Dong Yan, Hai Li, Gui-Qi Zhu, Yao-Yao Xie, Fa-Ling Wu, Yong-Ping Chen

Published Jul 15, 2015 · Vol. 6, No. 27 · pp. 23261-23271

Combination of antibodies directed against different ErbB3 surface epitopes prevents the establishment of resistance to BRAF/MEK inhibitors in melanoma Research Paper

Luigi Fattore, Debora Malpicci, Emanuele Marra, Francesca Belleudi, Alessia Noto, Claudia De Vitis, Maria Elena Pisanu, Pierpaolo Coluccia, Rosa Camerlingo, Giuseppe Roscilli, Antoni Ribas, Arianna Di Napoli, Maria Rosaria Torrisi, Luigi Aurisicchio, Paolo Antonio Ascierto, Rita Mancini, Gennaro Ciliberto

Published Jul 7, 2015 · Vol. 6, No. 28 · pp. 24823-24841

Identification of GALNT14 as a novel neuroblastoma predisposition gene Research Paper

Marilena De Mariano, Roberta Gallesio, Marco Chierici, Cesare Furlanello, Massimo Conte, Alberto Garaventa, Michela Croce, Silvano Ferrini, Gian Paolo Tonini, Luca Longo

Published Jul 3, 2015 · Vol. 6, No. 28 · pp. 26335-26346

Functional genomic mRNA profiling of a large cancer data base demonstrates mesothelin overexpression in a broad range of tumor types Research Paper

Laetitia E. Lamberts, Derk Jan A. de Groot, Rico D. Bense, Elisabeth G.E. de Vries, Rudolf S.N. Fehrmann

Published Jul 1, 2015 · Vol. 6, No. 29 · pp. 28164-28172

Prognostic impact of c-Rel nuclear expression and REL amplification and crosstalk between c-Rel and the p53 pathway in diffuse large B-cell lymphoma Priority Research Paper

Ling Li, Zijun Y. Xu-Monette, Chi Young Ok, Alexandar Tzankov, Ganiraju C. Manyam, Ruifan Sun, Carlo Visco, Mingzhi Zhang, Santiago Montes-Moreno, Karen Dybkaer, April Chiu, Attilio Orazi, Youli Zu, Govind Bhagat, Kristy L. Richards, Eric D. Hsi, William W.L. Choi, J. Han van Krieken, Jooryung Huh, Maurilio Ponzoni, AndrÃ©s J.M. Ferreri, Michael B. MÃ¸ller, Jinfeng Wang, Ben M. Parsons, Jane N. Winter, Miguel A. Piris, Lan V. Pham, L. Jeffrey Medeiros, Ken H. Young

Published Jun 30, 2015 · Vol. 6, No. 27 · pp. 23157-23180

Survival of primary, but not of cancer cells after combined Plk1-HDAC inhibition Research Paper

Lisa Lange, Peter Hemmerich, Birgit SpÃ¤nkuch

Published Jun 26, 2015 · Vol. 6, No. 28 · pp. 25801-25814

Glioma-derived plasminogen activator inhibitor-1 (PAI-1) regulates the recruitment of LRP1 positive mast cells Research Paper

Ananya Roy, Antoine Coum, Voichita D. Marinescu, Jelena PÃµlajeva, Anja Smits, Sven Nelander, Lene Uhrbom, Bengt Westermark, Karin Forsberg-Nilsson, Fredrik PontÃ©n, Elena Tchougounova

Published Jun 25, 2015 · Vol. 6, No. 27 · pp. 23647-23661

A fully human chimeric antigen receptor with potent activity against cancer cells but reduced risk for off-tumor toxicity Research Paper

De-Gang Song, Qunrui Ye, Mathilde Poussin, Lin Liu, Mariangela Figini, Daniel J. Powell Jr.

Published Jun 19, 2015 · Vol. 6, No. 25 · pp. 21533-21546

Mutational and gene fusion analyses of primary large cell and large cell neuroendocrine lung cancer Research Paper

Anna Karlsson, Hans BrunnstrÃ¶m, Kajsa Ericson Lindquist, Karin JirstrÃ¶m, Mats JÃ¶nsson, Frida Rosengren, Christel ReuterswÃ¤rd, Helena Cirenajwis, Ã…ke Borg, Per JÃ¶nsson, Maria Planck, GÃ¶ran JÃ¶nsson, Johan Staaf

Published Jun 17, 2015 · Vol. 6, No. 26 · pp. 22028-22037

Erratum: Clinical and biological significance of de novo CD5+ diffuse large B-cell lymphoma in Western countries Errata

Zijun Y. Xu-Monette, Meifeng Tu, Kausar J. Jabbar, Xin Cao, Alexandar Tzankov, Carlo Visco, Lalitha Nagarajan, Qinging Cai, Santiago Montes-Moreno, Yuji An, Karen Dybkaer, April Chiu, Attilio Orazi, Youli Zu, Govind Bhagat, Kristy L. Richards, Eric D. Hsi, William W.L. Choi, J. Han van Krieken, Jooryung Huh, Maurilio Ponzoni, AndrÃ©s J.M. Ferreri, Xiaoying Zhao, Michael B. MÃ¸ller, John P. Farnen, Jane N. Winter, Miguel A. Piris, Roberto N. Miranda, L. Jeffrey Medeiros, Ken H. Young

Published Jun 13, 2015 · Vol. 6, No. 16 · pp. 14720

Metabolic syndrome contributes to an increased recurrence risk of non-metastatic colorectal cancer Clinical Research Papers

Jie You, Wen-Yue Liu, Gui-Qi Zhu, Ou-Chen Wang, Rui-Min Ma, Gui-Qian Huang, Ke-Qing Shi, Gui-Long Guo, Martin Braddock, Ming-Hua Zheng

Published Jun 12, 2015 · Vol. 6, No. 23 · pp. 19880-19890

Inhibition of COP9-signalosome (CSN) deneddylating activity and tumor growth of diffuse large B-cell lymphomas by doxycycline Priority Research Paper

Mary Pulvino, Luojing Chen, David Oleksyn, Jing Li, George Compitello, Randy Rossi, Stephen Spence, Vijaya Balakrishnan, Craig Jordan, Brian Poligone, Carla Casulo, Richard Burack, Joel L. Shapiro, Steven Bernstein, Jonathan W. Friedberg, Raymond J. Deshaies, Hartmut Land, Jiyong Zhao

Published Jun 4, 2015 · Vol. 6, No. 17 · pp. 14796-14813

Publication Alerts

European Cancer and Oncology Congress

Post-Publication Promotion

Search Oncotarget

Rituximab-induced HMGB1 release is associated with inhibition of STAT3 activity in human diffuse large B-cell lymphoma Research Paper

Targeting SOD1 induces synthetic lethal killing in BLM- and CHEK2-deficient colorectal cancer cells Research Paper

Enhanced detection and comprehensive in situ phenotypic characterization of circulating and disseminated heteroploid epithelial and glioma tumor cells Research Paper

Analysis of SDHD promoter mutations in various types of melanoma Research Paper

Hepatitis B virus-associated diffuse large B-cell lymphoma: unique clinical features, poor outcome, and hepatitis B surface antigen-driven origin Research Paper

The MYC/miR-17-92 axis in lymphoproliferative disorders: A common pathway with therapeutic potential Review

OSI-027 inhibits pancreatic ductal adenocarcinoma cell proliferation and enhances the therapeutic effect of gemcitabine both in vitro and in vivo Research Paper

Genetic determinants of FOXM1 overexpression in epithelial ovarian cancer and functional contribution to cell cycle progression Research Paper

Conditional survival estimate of acute-on-chronic hepatitis B liver failure: a dynamic prediction based on a multicenter cohort Research Paper

Combination of antibodies directed against different ErbB3 surface epitopes prevents the establishment of resistance to BRAF/MEK inhibitors in melanoma Research Paper

Identification of GALNT14 as a novel neuroblastoma predisposition gene Research Paper

Functional genomic mRNA profiling of a large cancer data base demonstrates mesothelin overexpression in a broad range of tumor types Research Paper

Prognostic impact of c-Rel nuclear expression and REL amplification and crosstalk between c-Rel and the p53 pathway in diffuse large B-cell lymphoma Priority Research Paper

Survival of primary, but not of cancer cells after combined Plk1-HDAC inhibition Research Paper

Glioma-derived plasminogen activator inhibitor-1 (PAI-1) regulates the recruitment of LRP1 positive mast cells Research Paper

A fully human chimeric antigen receptor with potent activity against cancer cells but reduced risk for off-tumor toxicity Research Paper

Mutational and gene fusion analyses of primary large cell and large cell neuroendocrine lung cancer Research Paper

Erratum: Clinical and biological significance of de novo CD5+ diffuse large B-cell lymphoma in Western countries Errata

Metabolic syndrome contributes to an increased recurrence risk of non-metastatic colorectal cancer Clinical Research Papers

Inhibition of COP9-signalosome (CSN) deneddylating activity and tumor growth of diffuse large B-cell lymphomas by doxycycline Priority Research Paper

Publication Alerts

European Cancer and Oncology Congress

Oncoscience

Post-Publication Promotion

Search Oncotarget

Rituximab-induced HMGB1 release is associated with inhibition of STAT3 activity in human diffuse large B-cell lymphoma Research Paper

Targeting SOD1 induces synthetic lethal killing in BLM- and CHEK2-deficient colorectal cancer cells Research Paper

Enhanced detection and comprehensive in situ phenotypic characterization of circulating and disseminated heteroploid epithelial and glioma tumor cells Research Paper

Analysis of SDHD promoter mutations in various types of melanoma Research Paper

Hepatitis B virus-associated diffuse large B-cell lymphoma: unique clinical features, poor outcome, and hepatitis B surface antigen-driven origin Research Paper

The MYC/miR-17-92 axis in lymphoproliferative disorders: A common pathway with therapeutic potential Review

OSI-027 inhibits pancreatic ductal adenocarcinoma cell proliferation and enhances the therapeutic effect of gemcitabine both in vitro and in vivo Research Paper

Genetic determinants of FOXM1 overexpression in epithelial ovarian cancer and functional contribution to cell cycle progression Research Paper

Conditional survival estimate of acute-on-chronic hepatitis B liver failure: a dynamic prediction based on a multicenter cohort Research Paper

Combination of antibodies directed against different ErbB3 surface epitopes prevents the establishment of resistance to BRAF/MEK inhibitors in melanoma Research Paper

Identification of GALNT14 as a novel neuroblastoma predisposition gene Research Paper

Functional genomic mRNA profiling of a large cancer data base demonstrates mesothelin overexpression in a broad range of tumor types Research Paper

Prognostic impact of c-Rel nuclear expression and REL amplification and crosstalk between c-Rel and the p53 pathway in diffuse large B-cell lymphoma Priority Research Paper

Survival of primary, but not of cancer cells after combined Plk1-HDAC inhibition Research Paper

Glioma-derived plasminogen activator inhibitor-1 (PAI-1) regulates the recruitment of LRP1 positive mast cells Research Paper

A fully human chimeric antigen receptor with potent activity against cancer cells but reduced risk for off-tumor toxicity Research Paper

Mutational and gene fusion analyses of primary large cell and large cell neuroendocrine lung cancer Research Paper

Erratum: Clinical and biological significance of de novo CD5+ diffuse large B-cell lymphoma in Western countries Errata

Metabolic syndrome contributes to an increased recurrence risk of non-metastatic colorectal cancer Clinical Research Papers

Inhibition of COP9-signalosome (CSN) deneddylating activity and tumor growth of diffuse large B-cell lymphomas by doxycycline Priority Research Paper